HEART UK consensus statement on Lipoprotein(a): A call to action

Lipoprotein(a), Lp(a), is a modified atherogenic low-density lipoprotein particle that contains apolipoprotein(a). Its levels are highly heritable and variable in the population. This consensus statement by HEART UK is based on the evidence that Lp(a) is an independent cardiovascular disease (CVD) r...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Atherosclerosis Ročník 291; s. 62 - 70
Hlavní autoři:	Cegla, Jaimini, Neely, R.Dermot G., France, Michael, Ferns, Gordon, Byrne, Chris D., Halcox, Julian, Datta, Dev, Capps, Nigel, Shoulders, Carol, Qureshi, Nadeem, Rees, Alan, Main, Linda, Cramb, Robert, Viljoen, Adie, Payne, Jules, Soran, Handrean
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Ireland Elsevier B.V 01.12.2019
Témata:	Biomarkers - blood Blood Component Removal Cardiovascular Diseases - epidemiology Cardiovascular Diseases - prevention & control Cardiovascular risk Clinical Decision-Making Consensus Down-Regulation Dyslipidemias - blood Dyslipidemias - diagnosis Dyslipidemias - epidemiology Dyslipidemias - therapy Humans Hyperlipidemia Hypolipidemic Agents - therapeutic use Lipids Lipoprotein(a) Lipoprotein(a) - blood Lp(a) Myocardial infarction Risk Assessment Risk Factors Stroke Myocardial infarction Lipoprotein(a) Stroke Hyperlipidemia Cardiovascular risk Lipids Lp(a)
ISSN:	0021-9150, 1879-1484, 1879-1484
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!